Skip to content

Management of Cardiovascular Risk Factors

Management of Cardiovascular Risk Factors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00848380
Enrollment
1492
Registered
2009-02-20
Start date
2009-02-28
Completion date
2009-12-31
Last updated
2010-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cardiovascular Risk Factors

Keywords

Hypertension, hyperlipidemia

Brief summary

This practical experience should report a retrospective collection of data regarding cardiovascular risk factors of cardiovascular diseases. The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients received a anti-hypertension treatment in addition to cholesterol lowering treatment during the observation period * Patients received a cholesterol lowering treatment in addition to hypertension treatment during the observation period * Patients received during the observation time new cholesterol lowering and hypertension treatment

Exclusion criteria

* Patients received during the observation time only cholesterol lowering or only anti-hypertension treatment

Design outcomes

Primary

MeasureTime frame
The goal is an evaluation of the development of the risk profile of cardiovascular patients with simultaneous treatment of hypertension and hyperlipidemia.Inclusion visit, 6 to 9 months before inclusion visit and / or 12 to 15 months before inclusion visit

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026